Friday, October 28, 2011 12:05:32 PM
Who knows?
As AQLV have not conducted any of the pre-clinical or CMC work that would allow them to file an IND and conduct Phase I clinical studies and ADME studies that would start the characterization of the AquaLiv and NatuRx drugs, it's not possible to answer that question.
But that's precisely the reason that FDA and all Regulatory insist on rigorous procedures before such products are administered willy nilly to test subjects in uncontrolled unauthorised clinical trials in real patients such as AQLV's trial in ten Kenyan patients.
But we can assume that if indeed these drugs are effective in treating cancer and HIV/AIDS as Hoffman claims, then they must have profound effects on the immune system in general and on the cytokines, cell structures and metabolism in particular.
Therefore it's highly probable there will be many unwanted effects with the drugs.
As there seems to be a lack of specific knowledge about the drug development process among members of this community - and this lack of knowledge is often exploited by scam biopharma companies like AQLV - readers may find this primer helpful:
http://en.wikipedia.org/wiki/Clinical_trial
Please note from this source:
"Clinical trials are a set of procedures in medical research and drug development that are conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g., drugs, diagnostics, devices, therapy protocols). These trials can take place only after satisfactory information has been gathered on the quality of the non-clinical safety, and Health Authority/Ethics Committee approval is granted in the country where the trial is taking place."
"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."
Upton Sinclair
"Nobody ever went broke underestimating the intelligence of the American public."
H. L. Mencken
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM